State Street
TPST icon

State Street’s Tempest Therapeutics TPST Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-41,492
Closed -$30.6K 4320
2025
Q1
$30.6K Hold
41,492
﹤0.01% 4156
2024
Q4
$34.6K Hold
41,492
﹤0.01% 4167
2024
Q3
$58.1K Hold
41,492
﹤0.01% 4075
2024
Q2
$90.9K Hold
41,492
﹤0.01% 4033
2024
Q1
$162K Buy
41,492
+18,000
+77% +$70.4K ﹤0.01% 3921
2023
Q4
$103K Buy
+23,492
New +$103K ﹤0.01% 4049
2020
Q3
Sell
-14,957
Closed -$26K 3858
2020
Q2
$26K Sell
14,957
-163,685
-92% -$285K ﹤0.01% 3759
2020
Q1
$943K Buy
178,642
+11,906
+7% +$62.8K ﹤0.01% 3317
2019
Q4
$1.12M Buy
166,736
+21,493
+15% +$145K ﹤0.01% 3385
2019
Q3
$1.03M Buy
145,243
+28,718
+25% +$204K ﹤0.01% 3387
2019
Q2
$1.35M Buy
+116,525
New +$1.35M ﹤0.01% 3367
2018
Q4
Sell
-18,855
Closed -$14K 3785
2018
Q3
$14K Sell
18,855
-1,845
-9% -$1.37K ﹤0.01% 3752
2018
Q2
$18K Hold
20,700
﹤0.01% 3737
2018
Q1
$16K Sell
20,700
-500
-2% -$386 ﹤0.01% 3725
2017
Q4
$29K Hold
21,200
﹤0.01% 3670
2017
Q3
$30K Sell
21,200
-7,300
-26% -$10.3K ﹤0.01% 3700
2017
Q2
$43K Sell
28,500
-453,934
-94% -$685K ﹤0.01% 3606
2017
Q1
$903K Buy
482,434
+1,690
+0.4% +$3.16K ﹤0.01% 3289
2016
Q4
$731K Buy
480,744
+48,140
+11% +$73.2K ﹤0.01% 3338
2016
Q3
$3.1M Buy
432,604
+12,716
+3% +$91.1K ﹤0.01% 2802
2016
Q2
$2.19M Buy
419,888
+11,908
+3% +$62.1K ﹤0.01% 2997
2016
Q1
$3.88M Sell
407,980
-5,447
-1% -$51.8K ﹤0.01% 2682
2015
Q4
$4.04M Sell
413,427
-1,401,416
-77% -$13.7M ﹤0.01% 2641
2015
Q3
$15.4M Buy
1,814,843
+804,612
+80% +$6.83M ﹤0.01% 1926
2015
Q2
$29.2M Buy
1,010,231
+260,314
+35% +$7.53M ﹤0.01% 1598
2015
Q1
$26M Buy
749,917
+536,992
+252% +$18.7M ﹤0.01% 1660
2014
Q4
$9.42M Buy
212,925
+91,348
+75% +$4.04M ﹤0.01% 2248
2014
Q3
$2.02M Buy
121,577
+7,905
+7% +$131K ﹤0.01% 3010
2014
Q2
$1.04M Buy
113,672
+20,084
+21% +$184K ﹤0.01% 3244
2014
Q1
$835K Buy
93,588
+23,488
+34% +$210K ﹤0.01% 3279
2013
Q4
$639K Buy
70,100
+16,310
+30% +$149K ﹤0.01% 3323
2013
Q3
$533K Buy
53,790
+28,390
+112% +$281K ﹤0.01% 3339
2013
Q2
$349K Buy
+25,400
New +$349K ﹤0.01% 3279